# Phase 2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat

> **NCT00618618** · PHASE2 · COMPLETED · sponsor: **Kythera Biopharmaceuticals** · enrollment: 73 (actual)

## Conditions studied

- Moderate or Severe Submental Fullness

## Interventions

- **DRUG:** Deoxycholic Acid Injection
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00618618
- **Lead sponsor:** Kythera Biopharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2015-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00618618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00618618, "Phase 2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00618618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*